Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Meytav Technological Incubator is an Israeli life sciences incubator located in Kiryat Shmona, specializing in the development of early-stage biotechnology, pharmaceutical, and medical device startups. Founded in 1991, it operates under the framework of the Israel Innovation Authority's incubator program, providing essential funding, laboratory facilities, and business mentorship to bridge the gap between academic research and commercialization. In 2010, the incubator was acquired by BioLineRx, a clinical-stage biopharmaceutical company, to serve as a primary source for its drug development pipeline. Meytav focuses on identifying high-potential therapeutic candidates and medical technologies, supporting them through the critical proof-of-concept and early development phases. The incubator has been instrumental in fostering the biotech ecosystem in the Galilee region and has nurtured numerous companies that have progressed to clinical stages.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Meytav Technological Incubator.